You are here

CML Learning Objectives - Drs Druker/Talpaz/Sawyers

This conference write up is free to all but you do have to register to have access. A must for everyone who wants to know more about CML and Clinical Options.
Click below - then click on Begin expert analysis and Register.
Makes an interesting read.
Elizabeth
Clinical Option CML Conference

A very interesting read!

I was particularly interested in the comments upon the reported possible links between Glivec and cardiotoxicity.
It appears that the risks associated with Glivec therapy in terms of producing heart failure are NOT as prominent as would have been assumed from the article in 'Nature' last year.
Certainly the Haematologists contributing to this conference seem to consider a Glivec low risk in this respect.